Global Heart Scan Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

Heart Scan Market Analysis

The heart scan market is witnessing robust growth due to increasing cardiovascular disease prevalence, advancements in diagnostic technology, and rising health awareness globally. Heart scans, also known as cardiac imaging or coronary scans, are non-invasive procedures that help detect abnormalities in the heart and its blood vessels. These scans, including electron beam computed tomography (EBCT), nuclear heart scans, and echocardiograms, play a pivotal role in early diagnosis and preventive care. Recent developments, such as artificial intelligence integration in imaging systems and portable diagnostic devices, are enhancing diagnostic accuracy and accessibility. The market is further bolstered by government initiatives and healthcare programs aimed at reducing the burden of heart-related diseases. With increasing investments in R&D and growing demand for personalized healthcare, the heart scan market is poised for significant expansion. Key players are focusing on product innovations and strategic collaborations to meet the rising demand and improve patient outcomes.

Heart Scan Market Size

The global heart scan market size was valued at USD 15.97 billion in 2024 and is projected to reach USD 26.51 billion by 2032, with a CAGR of 6.54% during the forecast period of 2025 to 2032. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Heart Scan Market Trends

“Integration of Artificial Intelligence”

The heart scan market is evolving rapidly, driven by technological advancements and increasing awareness about early detection of cardiovascular diseases. Heart scans, such as echocardiograms and electron beam computed tomography (EBCT), are gaining traction for their non-invasive nature and precise diagnostic capabilities. A notable trend in the market is the integration of artificial intelligence (AI) in cardiac imaging. AI-powered diagnostic tools enhance accuracy by analyzing vast datasets, identifying subtle anomalies, and enabling personalized treatment plans. In addition, portable and wearable heart monitoring devices are reshaping diagnostics, offering convenience and real-time insights for patients and healthcare providers. These innovations, combined with the rising prevalence of cardiovascular diseases, are propelling the heart scan market towards significant growth globally.

Report Scope and Heart Scan Market Segmentation 

Heart Scan Market Definition

A heart scan is a diagnostic imaging procedure used to assess the health and function of the heart. It involves various techniques such as echocardiograms, coronary angiography, electron beam computed tomography (EBCT), and nuclear heart scans to detect conditions such as coronary artery disease, heart valve abnormalities, heart muscle problems, and other cardiovascular issues. Heart scans help identify potential risks, guide treatment decisions, and monitor the progression of heart disease, offering crucial insights into heart health.

Heart Scan Market Dynamics

Drivers

• Rising Prevalence of Cardiovascular Diseases

The rising incidence of heart diseases, particularly coronary artery disease, heart failure, and other cardiovascular conditions, is driving the demand for heart scan diagnostics. Early detection of these conditions is crucial for effective treatment and management, making heart scans an essential tool in healthcare. As heart diseases continue to be a leading cause of death globally, there is an increased emphasis on preventive care and timely intervention. This growing need for early diagnosis and better management is propelling the market for heart scan technologies, contributing to its expansion and evolution within the medical diagnostic field.

• Increased Awareness of Heart Health

Growing awareness about the importance of heart disease prevention is significantly driving the heart scan market. As individuals become more conscious of the risks associated with cardiovascular diseases, there is an increasing trend toward early detection through regular health screenings. Public health campaigns, along with greater access to information, are encouraging people to take proactive measures in managing their heart health. This shift in behavior is fostering demand for heart scan technologies and contributing to a larger focus on preventive healthcare, ultimately enhancing market growth and the adoption of heart scan diagnostics.

Opportunities

• Non-Invasive Procedures

The growing preference for non-invasive diagnostic methods, such as coronary computed tomography angiography (CTA), is a significant market opportunity in the heart scan sector. CTA provides a safer and quicker alternative to traditional invasive methods such as angiography, with the added benefit of detailed imaging to assess coronary artery disease. Its ability to detect blockages without the need for catheter insertion makes it an appealing option for both patients and healthcare providers. As patients increasingly seek less invasive procedures with faster recovery times, the demand for CTA is expected to rise, driving higher adoption rates and expanding market growth opportunities.

• Integration with Telemedicine

The rise of telemedicine and remote patient monitoring is also creating new avenues for heart scans. As healthcare systems evolve to offer more convenient and accessible services, patients can now receive diagnostic consultations and heart scans from the comfort of their homes. Telemedicine platforms allow physicians to interpret heart scan results remotely, providing real-time assessments and personalized care plans. This shift is particularly beneficial for patients in remote areas or those with limited access to specialized healthcare. The integration of heart scans with telemedicine solutions represents a key opportunity for market expansion, particularly in underserved regions.

Restraints/Challenges

• Limited Access in Rural Areas

Despite the significant growth of telemedicine, a major challenge for the heart scan market remains the lack of infrastructure in remote or rural areas. These regions often struggle with limited access to advanced healthcare technologies, including heart scan systems, due to insufficient medical facilities, specialized equipment, and trained personnel. Even though telemedicine has improved access to consultations and remote diagnostics, the absence of high-quality imaging equipment and connectivity issues still hinder the effective use of advanced heart scan technologies. As a result, many individuals in these underserved areas face delays in diagnosis and treatment, which limits the market’s growth potential.

•  High Cost of Advanced Heart Scan

The high cost of advanced heart scan technologies, such as coronary computed tomography angiography (CTA) and magnetic resonance imaging (MRI), presents a significant market restraint. These cutting-edge imaging techniques require expensive equipment, maintenance, and skilled personnel, making them costly for both healthcare providers and patients. In low-resource settings, the financial burden can limit access to these technologies, as healthcare systems may not have the budget to invest in advanced equipment. This cost barrier prevents a large portion of the population from benefiting from timely and accurate heart diagnostics, thereby hindering the widespread adoption and growth of the heart scan market.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Heart Scan Market Scope

The market is segmented on the basis of type, indication, and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Electron Beam Computed Tomography
• Nuclear Heart Scan
• Echocardiogram
• Cardiac Catheterization
• Coronary Arteriography
• Angiocardiography
• Others

Indication

• Congenital Heart Diseases
• Coronary Artery Blockage
• Defects or Injuries to the Heart’s Four Primary Valves
• Blood Clots within the Heart
• Tumours in or on the Heart
• Others

End-User

• Hospitals and Clinics
• Diagnostic Centers
• Cardiac Care Centers
• Ambulatory Centers
• Home Care
• Academic Institutes
• Others

Heart Scan Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, type, indication, and end user as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America holds a prominent share of the heart scan market, primarily due to the high prevalence of cardiovascular diseases and the presence of advanced healthcare infrastructure. The region benefits from widespread adoption of cutting-edge technologies such as coronary computed tomography angiography (CTA) and magnetic resonance imaging (MRI), along with significant investments in medical research and development.

The Asia-Pacific region is experiencing rapid growth in the heart scan market, driven by the increasing prevalence of cardiovascular diseases and a growing elderly population. Rising disposable incomes and greater investments in healthcare infrastructure, particularly in developing countries, are fueling market expansion. In addition, technological advancements in the region are creating significant opportunities for further growth.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.  

Heart Scan Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Heart Scan Market Leaders Operating in the Market Are:

• Terumo Medical Corporation (Japan)
• Getinge (Sweden)
• Medtronic (U.S.)
• Edwards Lifesciences Corporation (U.S.)
• Smiths Group plc (U.K.)
• Teleflex Incorporated (U.S.)
• Johnson & Johnson Services, Inc. (U.S.)
• Abbott (U.S.)
• Dispocard GmbH (Germany)
• Coloplast Corp. (Denmark)
• Boston Scientific Corporation (U.S.)
• General Electric Company (U.S.)
• Tinomed Healthcare Private Limited (India)
• S N Medical Systems (India)
• Paras Health (India)
• Elesonic Healthcare Pvt. Ltd (India)
• Ansh Healthcare (India)
• OMEGA MEDSURGE (India)
• Hi Tech Medi Systems (India)

Latest Developments in Heart Scan Market

• In February 2023, Abbott acquired Cardiovascular Systems Inc. (CSI), strengthening its position in the market with advanced diagnostic products. This acquisition provided Abbott with access to CSI's cutting-edge atherectomy devices, which are highly effective in treating vascular diseases. The move enhanced Abbott's portfolio, giving it a competitive advantage in the cardiovascular space
• In 2023, Siemens unveiled its Somatom Pro.Pulse at RSNA, offering high-resolution cardiac imaging at an affordable cost, specifically designed for patients with elevated heart rates. Likewise, Canon introduced the Aquilion One Insight Edition, which provides complete heart scans in a single rotation, significantly reducing imaging time and enhancing efficiency. These innovations highlight advancements in cardiac imaging, improving both affordability and patient care
• In September 2021, AstraZeneca India collaborated with Bengaluru-based startup Tricog to launch Project Heart Beat. This initiative aimed to improve heart disease diagnosis and treatment using advanced technology. The partnership focused on leveraging Tricog’s AI-driven solutions to enhance cardiovascular care across India
• In April 2021, Roche introduced a series of five new applications for two key cardiac biomarkers—highly sensitive cardiac troponin T (cTnT-hs) and N-terminal pro-brain natriuretic peptide (NT-proBNP) tests—using its Elecsys® technology. This expansion aimed to enhance the diagnostic capabilities for heart-related conditions. The new tests improve early detection and monitoring, offering healthcare providers advanced tools for cardiovascular disease management

SKU-60546